I can only but agree with you @KrushingIt , The issue for me is...

I can only but agree with you @KrushingIt , The issue for me is not the Science but the anchor the company has caused with SOI and the SP collapse ,, plus Big Pharma are not fools ,, if the Tech to them was of significant value they can just start buying on market acquire 20% and place in a couple of Board Members.. then drive a licensing deal..

The Value of the Therapies has been significantly hindered by managements (BOD) sitting idle watching the SP and SH value erode..
Science Team is of significant value ... Therapies still require further Trialing but all current data points to success..

In 25 years I had not seen a CR broadcast with such a long runway, then Nothing ,,fkn crickets,,, then when they failed to meet the 2Q operating Capital and didn't file in the regulatory timeframe they were suspended , I'm not stating this was deliberate but then the CR done with the free option just showed the market what CHM BOD members what value they placed on the current SH base.. excluded from participation at ALL TIME LOWS that were basically caused by the BOD actions,,, seen it before as you would have ,,, no matter what the Optic is very poor.. and the market know it... TBH I'm surprised the regulators didn't step in..

I know several large holders here ,,, once there is daylight with the SP above 3c the exodus will be significant NZT